← Leaderboards
Shanjana Awasthi
Oklahoma State University Stillwater
$3,005,645
Attributed
$3,005,645
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $575.9K · FY2013–21$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,005,645 · 2
By mechanism
R01$1,790,000 · 1
P20$1,215,645 · 1
Top collaborators
No co-investigators on record.
Most similar at Oklahoma State University Stillwater
Same institution · by research overlap
- Lin Liu$25,677,420
- Telugu Narasaraju$1,232,967
- Jerry W Ritchey$1,497,497
- Antonius G Oomens$1,991,770
- Heather Gappa-Fahlenkamp$1,221,747
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsPeptidesInfectionLipopolysaccharidesPathogenN-TerminalImmuneImmunotherapeutic AgentLeadInjuryAdult Respiratory Distress SyndromeLungBaseMorbidity - Disease RateCytokineHost DefenseImmunomodulatorsBiologicalInflammatoryInflammationAnti-Inflammatory AgentsInflammatory ResponseCellsPharmacotherapy
Grant awards (10)
Surfactant protein-A regions as TLR4-immunomodulators$362,500
R01 · FY2021 · HL · contact PI
Surfactant protein-A regions as TLR4-immunomodulators$362,500
R01 · FY2020 · HL · contact PI
Surfactant protein-A regions as TLR4-immunomodulators$362,500
R01 · FY2019 · HL · contact PI
Surfactant protein-A regions as TLR4-immunomodulators$362,500
R01 · FY2018 · HL · contact PI
Surfactant protein-A regions as TLR4-immunomodulators$340,000
R01 · FY2017 · HL · contact PI
Control of Lung Inflammation by a TLR4-interacting SPA-derived Peptide$235,852
P20 · FY2017 · GM · contact PI
Control of Lung Inflammation by a TLR4-interacting SPA-derived Peptide$238,910
P20 · FY2016 · GM · contact PI
Control of Lung Inflammation by a TLR4-interacting SPA-derived Peptide$242,009
P20 · FY2015 · GM · contact PI
Control of Lung Inflammation by a TLR4-interacting SPA-derived Peptide$247,274
P20 · FY2014 · GM · contact PI
Control of Lung Inflammation by a TLR4-interacting SPA-derived Peptide$251,600
P20 · FY2013 · GM · contact PI